Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1778 participants
OBSERVATIONAL
2012-01-31
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medtronic Market-Released DF4 Lead Imaging
NCT01626768
Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector
NCT03766919
DF4 Master Study (Safety and Efficacy Study)
NCT01790841
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
NCT00869921
OptiLink HF Study: Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink Network
NCT00769457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is intended to be implanted or is within 30 days post-implant of a DF4 Connector System with a Medtronic DF4 lead used for a pacing, sensing and/or defibrillation application
Exclusion Criteria
* Implant and follow-up data, including any adverse device effects and system modifications at implant through the time of enrollment are unavailable
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Anchorage, Alaska, United States
Gilbert, Arizona, United States
Scottsdale, Arizona, United States
Jonesboro, Arkansas, United States
Little Rock, Arkansas, United States
Bakersfield, California, United States
Chula Vista, California, United States
Rancho Mirage, California, United States
Salinas, California, United States
San Diego, California, United States
San Francisco, California, United States
Torrance, California, United States
Van Nuys, California, United States
Colorado Springs, Colorado, United States
Lakewood, Colorado, United States
Newark, Delaware, United States
Washington D.C., District of Columbia, United States
Bradenton, Florida, United States
Clearwater, Florida, United States
Albany, Georgia, United States
Atlanta, Georgia, United States
Marietta, Georgia, United States
Indianapolis, Indiana, United States
Des Moines, Iowa, United States
Kansas City, Kansas, United States
Edgewood, Kentucky, United States
Louisville, Kentucky, United States
Baton Rouge, Louisiana, United States
Hyattsville, Maryland, United States
Takoma Park, Maryland, United States
Worcester, Massachusetts, United States
Lansing, Michigan, United States
Marquette, Michigan, United States
Robbinsdale, Minnesota, United States
Saint Louis Park, Minnesota, United States
Saint Paul, Minnesota, United States
Columbia, Missouri, United States
Kansas City, Missouri, United States
St Louis, Missouri, United States
Henderson, Nevada, United States
Morristown, New Jersey, United States
Albuquerque, New Mexico, United States
Garden City, New York, United States
Huntington, New York, United States
New York, New York, United States
Poughkeepsie, New York, United States
Utica, New York, United States
Durham, North Carolina, United States
Raleigh, North Carolina, United States
Winston-Salem, North Carolina, United States
Akron, Ohio, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Toledo, Ohio, United States
Allentown, Pennsylvania, United States
Erie, Pennsylvania, United States
Lancaster, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Germantown, Tennessee, United States
Kingsport, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Plano, Texas, United States
The Woodlands, Texas, United States
Burlington, Vermont, United States
Olympia, Washington, United States
Spokane, Washington, United States
Tacoma, Washington, United States
Madison, Wisconsin, United States
Milwaukee, Wisconsin, United States
Calgary, Alberta, Canada
Kingston, Ontario, Canada
Montreal, Quebec, Canada
Québec, Quebec, Canada
Trois-Rivières, Quebec, Canada
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DF4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.